Trial Profile
Randomized comparative trial of vonoprazan and esomeplazole in triple therapy for eradication of Helicobacter pylori.
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 16 Oct 2021
Price :
$35
*
At a glance
- Drugs Vonoprazan (Primary) ; Esomeprazole
- Indications Helicobacter pylori infections
- Focus Therapeutic Use
- Acronyms P-CAB; VEHP
- 16 Aug 2019 Planned number of patients changed from 340 to 520.
- 01 Nov 2017 Results assessing superiority of Vonoprazan Versus Esomeprazole presented at the 25th United European Gastroenterology Week
- 13 Feb 2017 Status changed from recruiting to active, no longer recruiting.